{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:09:35Z","timestamp":1794546575465,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajo.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:01:27Z","timestamp":1729141287000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combination of Pretarsal and Preseptal Botulinum Toxin Injections in the Treatment of Blepharospasm: A Prospective Nonrandomized Clinical Trial"],"prefix":"10.1016","volume":"270","author":[{"given":"JUNHAO","family":"HU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QINYING","family":"MU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FUHAO","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIYI","family":"CHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MING","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ajo.2024.10.007_bib0001","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1001\/jama.1982.03330230060037","article-title":"Blinking and blepharospasm. Mechanism, diagnosis, and management","volume":"248","author":"Jankovic","year":"1982","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ajo.2024.10.007_bib0002","first-page":"371","article-title":"Blepharospasm: demographic and clinical survey of 250 patients","volume":"16","author":"Jankovic","year":"1984","journal-title":"Ann Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.10.007_bib0003","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.46.5.1213","article-title":"Blepharospasm: report of a workshop","volume":"46","author":"Hallett","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ajo.2024.10.007_bib0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ICU.0000000000000500","article-title":"Developments in the treatment of benign essential blepharospasm","volume":"29","author":"Yen","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.10.007_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/toxins12040269","article-title":"Treatment of blepharospasm and oromandibular dystonia with botulinum toxins","volume":"12","author":"Hassell","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.ajo.2024.10.007_bib0006","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/mds.26934","article-title":"Blepharospasm 40 years later","volume":"32","author":"Defazio","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ajo.2024.10.007_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mds.870030107","article-title":"Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs","volume":"3","author":"Greene","year":"1988","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ajo.2024.10.007_bib0008","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.29.8.1126","article-title":"Meige disease: striatal dopaminergic preponderance","volume":"29","author":"Tolosa","year":"1979","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ajo.2024.10.007_bib0009","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.WNL.0000027361.73814.0E","article-title":"Blepharospasm: recent advances","volume":"59","author":"Hallett","year":"2002","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ajo.2024.10.007_bib0010","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/01.WNL.0000068527.25191.78","article-title":"Bilateral pallidal stimulation for blepharospasm-oromandibular dystonia (Meige syndrome)","volume":"60","author":"Capelle","year":"2003","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.ajo.2024.10.007_bib0011","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ajo.2024.10.007_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur J Neurol"},{"issue":"suppl 1","key":"10.1016\/j.ajo.2024.10.007_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1468-1331.2010.03045.x","article-title":"Craniocervical dystonia: clinical and pathophysiological features","volume":"17","author":"Colosimo","year":"2010","journal-title":"Eur J Neurol"},{"issue":"19","key":"10.1016\/j.ajo.2024.10.007_bib0014","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ajo.2024.10.007_bib0015","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10072-017-3107-2","article-title":"A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques","volume":"38","author":"Lolekha","year":"2017","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.ajo.2024.10.007_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-013-1526-2","article-title":"The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm","volume":"35","author":"Esposito","year":"2014","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.ajo.2024.10.007_bib0017","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.60.6.704","article-title":"Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening","volume":"60","author":"Jankovic","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ajo.2024.10.007_bib0018","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"issue":"1-2","key":"10.1016\/j.ajo.2024.10.007_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neurol.2020.03.022","article-title":"Botulinum toxin for benign essential blepharospasm: a systematic review and an algorithmic approach","volume":"177","author":"Rayess","year":"2021","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"10.1016\/j.ajo.2024.10.007_bib0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.60.6.693-a","article-title":"Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients","volume":"60","author":"Albanese","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ajo.2024.10.007_bib0021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp.59.3.309","article-title":"Pretarsal application of botulinum toxin for treatment of blepharospasm","volume":"59","author":"Aramideh","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"suppl","key":"10.1016\/j.ajo.2024.10.007_bib0022","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.4103\/0028-3886.226439","article-title":"Dystonia: a review","volume":"66","author":"Batla","year":"2018","journal-title":"Neurol India"},{"issue":"3","key":"10.1016\/j.ajo.2024.10.007_bib0023","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.22368","article-title":"Relationship between various clinical outcome assessments in patients with blepharospasm","volume":"24","author":"Jankovic","year":"2009","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ajo.2024.10.007_bib0024","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.35.6.339","article-title":"Observations upon the movements of the eyelids","volume":"35","author":"Gordon","year":"1951","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.10.007_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IOP.0000000000000430","article-title":"Regional variations in orbicularis oculi histology","volume":"31","author":"Costin","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.ajo.2024.10.007_bib0026","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period","volume":"17","author":"Hsiung","year":"2002","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ajo.2024.10.007_bib0027","doi-asserted-by":"crossref","first-page":"e28543","DOI":"10.1016\/j.heliyon.2024.e28543","article-title":"Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.ajo.2024.10.007_bib0028","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/toxins14050362","article-title":"Therapeutic approach to botulinum injections for hemifacial spasm, synkinesis and blepharospasm","volume":"14","author":"Yahalom","year":"2022","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.ajo.2024.10.007_bib0029","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm\u2014a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Movement Disord"},{"issue":"5","key":"10.1016\/j.ajo.2024.10.007_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","article-title":"Blepharospasm: past, present, and future","volume":"14","author":"Anderson","year":"1998","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.ajo.2024.10.007_bib0031","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.ajo.2024.10.007_bib0032","first-page":"133","article-title":"Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study","volume":"26","author":"Taylor","year":"1991","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.10.007_bib0033","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1442-9071.1994.tb00793.x","article-title":"Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm","volume":"22","author":"Price","year":"1994","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.10.007_bib0034","first-page":"493","article-title":"Local side effects of botulinum toxin injections","volume":"49","author":"Patrinely","year":"1988","journal-title":"Adv Neurol"},{"issue":"12","key":"10.1016\/j.ajo.2024.10.007_bib0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archotol.1988.01860240057024","article-title":"Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)","volume":"114","author":"Biglan","year":"1988","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.ajo.2024.10.007_bib0036","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum A toxin in the treatment of blepharospasm","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942400477X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942400477X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:09:37Z","timestamp":1737518977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942400477X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S000293942400477X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.10.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Pretarsal and Preseptal Botulinum Toxin Injections in the Treatment of Blepharospasm: A Prospective Nonrandomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}